PerkinElmer (PKI) To Provide NGS Solutions to Macrogen
Tweet
Share
E-mailGet Alerts PKI Hot Sheet
Join SI Premium – FREE
PerkinElmer, Inc. (NYSE: PKI) announced an agreement to provide Next Generation Sequencing (NGS) sample preparation solutions to Macrogen, Inc., a Korean-based global sequencing company.
As part of the agreement, PerkinElmer will provide Macrogen with its Sciclone® NGS Workstation for high throughput automated Next Generation Sequencing sample preparation, the LabChip® XT nucleic acid size selection and collection system, and the LabChip® GX nucleic acid separation system, to automate and increase the company’s sequencing analysis efficiency and throughput.
As part of the agreement, PerkinElmer will provide Macrogen with its Sciclone® NGS Workstation for high throughput automated Next Generation Sequencing sample preparation, the LabChip® XT nucleic acid size selection and collection system, and the LabChip® GX nucleic acid separation system, to automate and increase the company’s sequencing analysis efficiency and throughput.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
